186 related articles for article (PubMed ID: 25219807)
1. Genetic markers in adult high-grade gliomas.
Pekmezci M; Perry A
Semin Radiat Oncol; 2014 Oct; 24(4):235-9. PubMed ID: 25219807
[TBL] [Abstract][Full Text] [Related]
2. Diagnostic and prognostic molecular markers in common adult gliomas.
Rivera AL; Pelloski CE
Expert Rev Mol Diagn; 2010 Jul; 10(5):637-49. PubMed ID: 20629512
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic and prognostic markers in gliomas - an update.
Ma R; de Pennington N; Hofer M; Blesing C; Stacey R
Br J Neurosurg; 2013 Jun; 27(3):311-5. PubMed ID: 23278177
[TBL] [Abstract][Full Text] [Related]
4. Applications of molecular neuro-oncology - a review of diffuse glioma integrated diagnosis and emerging molecular entities.
Wood MD; Halfpenny AM; Moore SR
Diagn Pathol; 2019 Apr; 14(1):29. PubMed ID: 30967140
[TBL] [Abstract][Full Text] [Related]
5. Integrated molecular analysis suggests a three-class model for low-grade gliomas: a proof-of-concept study.
Marko NF; Prayson RA; Barnett GH; Weil RJ
Genomics; 2010 Jan; 95(1):16-24. PubMed ID: 19835948
[TBL] [Abstract][Full Text] [Related]
6. Molecular changes in gliomas.
Sanson M; Thillet J; Hoang-Xuan K
Curr Opin Oncol; 2004 Nov; 16(6):607-13. PubMed ID: 15627025
[TBL] [Abstract][Full Text] [Related]
7. Tailored therapy in diffuse gliomas: using molecular classifiers to optimize clinical management.
Taylor JW; Chi AS; Cahill DP
Oncology (Williston Park); 2013 Jun; 27(6):504-14. PubMed ID: 23909061
[TBL] [Abstract][Full Text] [Related]
8. Practical molecular pathologic diagnosis of infiltrating gliomas.
Pekmezci M; Perry A
Surg Pathol Clin; 2015 Mar; 8(1):49-61. PubMed ID: 25783821
[TBL] [Abstract][Full Text] [Related]
9. Central nervous system.
Adamson DC; Rasheed BA; McLendon RE; Bigner DD
Cancer Biomark; 2010; 9(1-6):193-210. PubMed ID: 22112477
[TBL] [Abstract][Full Text] [Related]
10. Genomic Biomarker Assessment in Gliomas: Impacts of Molecular Testing on Clinical Practice and Trial Design.
Lim-Fat MJ; Nayak L; Meredith DM
Surg Pathol Clin; 2020 Jun; 13(2):209-215. PubMed ID: 32389262
[TBL] [Abstract][Full Text] [Related]
11. Clinical Laboratory Testing Practices in Diffuse Gliomas Prior to Publication of 2021 World Health Organization Classification of Central Nervous System Tumors.
Ramkissoon SH; Fernandes H; Lopez-Terrada DH; Hameed MR; Trembath DG; Bridge JA; Lindeman NI; Souers RJ; Vasalos P; Brat DJ; Moncur JT
Arch Pathol Lab Med; 2022 May; 147(5):518-524. PubMed ID: 35878398
[TBL] [Abstract][Full Text] [Related]
12. Molecular biomarkers in pediatric glial tumors: a needed wind of change.
Fontebasso AM; Bechet D; Jabado N
Curr Opin Oncol; 2013 Nov; 25(6):665-73. PubMed ID: 24097106
[TBL] [Abstract][Full Text] [Related]
13. Prognostic and Predictive Biomarkers in Gliomas.
Śledzińska P; Bebyn MG; Furtak J; Kowalewski J; Lewandowska MA
Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638714
[TBL] [Abstract][Full Text] [Related]
14. The molecular landscape of diffuse glioma and prospects for biomarker development.
Huse JT; Aldape KD
Expert Opin Med Diagn; 2013 Nov; 7(6):573-87. PubMed ID: 24161073
[TBL] [Abstract][Full Text] [Related]
15. Gliomas: New Perspectives in Diagnosis, Treatment and Prognosis.
Ghotme KA; Barreto GE; Echeverria V; Gonzalez J; Bustos RH; Sanchez M; Leszek J; Yarla NS; Gomez RM; Tarasov VV; Ashraf GM; Aliev G
Curr Top Med Chem; 2017; 17(12):1438-1447. PubMed ID: 28049399
[TBL] [Abstract][Full Text] [Related]
16. [Clinico-pathological and molecular aspects of diagnostic and prognostic value in gliomas].
Ortega-Aznar A; Jimenez-Leon P; Martinez E; Romero-Vidal FJ
Rev Neurol; 2013 Feb; 56(3):161-70. PubMed ID: 23359078
[TBL] [Abstract][Full Text] [Related]
17. The evolving role of molecular markers in the diagnosis and management of diffuse glioma.
Huse JT; Aldape KD
Clin Cancer Res; 2014 Nov; 20(22):5601-11. PubMed ID: 25398843
[TBL] [Abstract][Full Text] [Related]
18. Advances in the molecular genetics of gliomas - implications for classification and therapy.
Reifenberger G; Wirsching HG; Knobbe-Thomsen CB; Weller M
Nat Rev Clin Oncol; 2017 Jul; 14(7):434-452. PubMed ID: 28031556
[TBL] [Abstract][Full Text] [Related]
19. Progress on molecular biomarkers and classification of malignant gliomas.
Zhang C; Bao Z; Zhang W; Jiang T
Front Med; 2013 Jun; 7(2):150-6. PubMed ID: 23681890
[TBL] [Abstract][Full Text] [Related]
20. The Evolving Classification of Diffuse Gliomas: World Health Organization Updates for 2021.
Perez A; Huse JT
Curr Neurol Neurosci Rep; 2021 Nov; 21(12):67. PubMed ID: 34817712
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
